Article

Axonal injury in the cerebral normal-appearing white matter of patients with multiple sclerosis is related to concurrent demyelination in lesions but not to concurrent demyelination in normal-appearing white matter.

Department of Neurology and Neurosurgery, Montreal Neurological Institute and Hospital, Montreal, Quebec, Canada H3A 2B4.
NeuroImage (Impact Factor: 6.25). 02/2006; 29(2):637-42. DOI: 10.1016/j.neuroimage.2005.07.017
Source: PubMed

ABSTRACT We assessed axonal injury and demyelination in the cerebral normal-appearing white matter (NAWM) of MS patients in a pilot study using proton magnetic resonance spectroscopic imaging and quantitative magnetization transfer (MT) imaging. Resonance intensities of N-acetylaspartate (NAA) relative to creatine (Cr) were measured in a large central brain volume. NAA/Cr in NAWM was estimated by regression of the NAA/Cr in each voxel against white matter fraction and extrapolation to a white matter fraction of 1. The fractional size of the semi-solid pool (F) was obtained from the binary spin bath model of MT by computing the model parameters from multiple MT-weighted and relaxometry acquisitions. F in NAWM was significantly smaller in the patients [0.109 (0.009)] relative to controls [0.123 (0.007), P = 0.011], but did not differ between RR [0.1085] and SP [0.1087] patients [P > 0.99]. NAA/Cr and F in the NAWM were not correlated (r = 0.16, P > 0.7), mainly due to a lack of variation in F among patients. This may indicate a floor to the extent of myelin pathology that can occur in NAWM before a lesion appears, or that axonal damage is not strictly related to demyelination. The correlation between NAWM NAA/Cr and T2w lesion volume was not significant (P > 0.1). However, dividing the lesion volumes by the mean F in T2w lesions resulted in a quantity that correlated well with NAWM NAA/Cr (r = -0.78, P = 0.038), possibly reflecting the association of Wallerian degeneration in the NAWM with axonal transection associated with demyelination within lesions.

1 Bookmark
 · 
67 Views
  • [Show abstract] [Hide abstract]
    ABSTRACT: The development and application of biomarkers to neurodegenerative diseases has become increasingly important in clinical practice and therapeutic trials. While substantial progress has been made at the basic science level in understanding the pathophysiology of HIV-Associated Neurocognitive Disorders (HAND), there are significant limitations in our current ability to predict the onset or trajectory of disease, and to accurately determine the effects of therapeutic interventions. Thus, the development of objective biomarkers is critical to further our understanding and treatment of HAND. In recent years, biomarker discovery efforts have largely been driven forward through the implementation of multiple "omics" approaches that include (but are not restricted to): Lipidomics, proteomics, metabolomics, genomics, transcriptomics, and advances in brain imaging approaches such as functional connectomics. In this paper we summarize our progress to date on lipidomic approaches to biomarker discovery, discuss how these data have influenced basic research on the neuropathology of HAND, and implications for the development of therapeutics that target metabolic pathways involved in lipid handling.
    Journal of Neuroimmune Pharmacology 11/2013; · 3.80 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: A modified model for wavelength conversion based on the four-wave mixing (FWM) in a silicon micro-ring resonator is presented. Unlike previous contributions, the nonlinear phase shifts caused by self-phase modulation and cross-phase modulation are also taken into account in the present theoretical analysis besides the linear propagation loss and the nonlinear losses caused by two-photon absorption and free-carrier absorption. Analysis shows that the nonlinear phase shifts will cause different red shifts for the pump and signal (or converted) resonant wavelengths, and consequently an additional wavelength difference between the signal transmission dip and the efficiency peak, which will increase/decrease the conversion efficiency of the signal channel far from/near the pump. The conversion efficiency and the conversion peak width of each signal channel are both affected by the micro-ring radius and coupling coefficient. A broader conversion peak width can be obtained by using a micro-ring resonator with a smaller Q factor.
    Optics Communications 01/2011; 284(8):2215-2221. · 1.44 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Magnetic resonance imaging (MRI) is the most important paraclinical measure for assessing and monitoring the pathologic changes implicated in the onset and progression of demyelinating and ischemic disorders. Conventional MRI sequences, such as T2-weighted imaging are unable to provide full details about the degree of inflammation and underlying neu- rodegenerative changes. Newer non-conventional MRI techniques have the potential to detect clinical impairment, disease progression, accumulation of disability, and the neuroprotective effects of treatment. The measurement of brain atrophy seems to be of growing clinical relevance as a biomarker of the disease process. Atrophy should now be included as a secondary end- point in trials of therapies aimed at limiting disease progression. Magnetization transfer imaging is increasingly used to characterize the evolution of lesions and normal-appearing brain tissue. Magnetic resonance spec-troscopy, which provides details on tissue biochemistry, metabolism, and function, also has the capacity to reveal neurodegeneration and neuroprotective mechanisms. By measuring the motion of water, diffusion imaging can provide information about the orientation, size, and geometry of tissue damage in white and gray matter. Functional MRI and other nuclear functional techniques may help clarify the brain's plasticity- and receptor-dependent compensatory mechanisms in patients with a variety of neurologic disorders. New techniques that might bring new information to the field include studies of microglial activation and studies using multiple single photon emission computed tomography (SPECT) and positron emission tomography (PET) tracers. All these techniques are useful in establishing diagnosis, monitoring disease activity, measuring therapeutic effect and explaining the development of disability in the short-and long-term. The role of these techniques in discerning neurobehavioral and neuropsychiatric symptoms in neurodegenerative (emphasizing Parkinson's Disease and Dementia with Lewy Bodies), ischemic and demyelinating disorders will be discussed.